FDA clears Zimmer Biomet’s Persona knee implant

Zimmer Biomet (NYSE:ZBH) said today that the FDA granted 510(k) clearance for its Persona revision knee implant.

Warsaw, Ind.-based Zimmer said the Persona system is designed to match each patient’s unique anatomy with customized components.

“The clearance of the Persona revision knee system gives us the ability to provide surgeons with a full service portfolio for the continuum of knee arthroplasty care, from diagnostic tools, cement spacer technologies to re-implantation solutions,” vice president Todd Davis said in prepared remarks. “The Persona revision knee system gives surgeons the flexibility to truly tailor an implant solution based on each patient’s unique anatomy for a natural fit and function.”

“Given the complexity of revision procedures and the fact that every person’s anatomy is a little different, it is critical for a knee revision system to give surgeons the ability to personalize the treatment strategy in order to achieve the best outcome for each patient,” added Dr. Giles Scuderi of New York City’s Northwell Health Physician Partners.

The post FDA clears Zimmer Biomet’s Persona knee implant appeared first on MassDevice.

from MassDevice https://ift.tt/2Q92hrH